Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
NEW YORK (Reuters Health) – Mild and moderate sequelae of Bell’s palsy at 12 months are reduced when prednisolone is given within 72 hours of symptom onset, according…
NEW YORK (Reuters Health) – Compared to cholecystectomy, percutaneous gallbladder drainage for acute cholecystitis is associated with longer recovery, higher morbidity and a trend toward lower survival, according…
NEW YORK (Reuters Health) – Two Spanish studies in the Journal of the American Medical Association report on long-term outcomes of continuous positive airway pressure (CPAP) therapy for…
NEW YORK (Reuters Health) – Adding hypertonic saline inhalation to bronchodilator therapy for young children seen in the emergency department with acute wheezing reduces admission rates and lengths…
NEW YORK (Reuters Health) – Dyspnea in patients with malignant pleural effusion is relieved to a similar degree with use of either indwelling pleural catheters (IPCs) or chest…
NEW YORK (Reuters Health) – Statin use before a stroke and during hospitalization is associated with a greater likelihood of being discharged home, while statin therapy withdrawal in…
Brachytherapy has become increasingly and commonly used in the United States to treat breast cancer after a lumpectomy. Although this therapy and the standard treatment, whole breast irradiation,…
NEW YORK (Reuters Health) – Using local anesthesia and fluoroscopic guidance is a simplified and effective means of transfemoral aortic valve replacement (TAVR), using the SAPIEN or newer…
NEW YORK (Reuters Health) – Active surveillance (“watchful waiting”) of small renal masses offers short term results equivalent to those with immediate surgery, researchers from UK report in…
NEW YORK (Reuters Health) – Once-daily mesalamine, at a dose of 2.4 g, offers maintenance of remission of ulcerative colitis similar to that provided by twice-daily mesalamine at…
